comparemela.com

Latest Breaking News On - Bone marrow transplantation - Page 30 : comparemela.com

Improving CAR-based-immunotherapies using a molecular anchor

After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm

Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.